Modular Medical, Inc. rose 2.82% in after-hours trading. The company's stock price increase may be attributed to the recent news event where Trinity Biotech plc unveiled its new product, CGM+, a next-generation wearable biosensor platform designed for the $260 billion AI wearables market. This innovative product combines multi-sensor data and real-time analytics to meet the evolving demands of AI-powered healthcare and wellness, which could positively impact the stock price of Modular Medical, Inc.
Comments
No comments yet